Toggle light / dark theme

How does it feel to live with a cerebral implant?

How looks life with na implant in brain.


Brain-computer interface technology is a fast-growing field but how does it feel to live with an implant inside of you?

In 2014, Ian Burkhart looked down at his hand and imagined closing it. To his astonishment, his hand did just that.

This was the first time a paraplegic person had regained the ability to move his arm by the sheer force of his thought, assisted by an implant in his brain.

Could the Universe be a giant quantum computer?

In their 1982 paper, Fredkin and Toffoli had begun developing their work on reversible computation in a rather different direction. It started with a seemingly frivolous analogy: a billiard table. They showed how mathematical computations could be represented by fully reversible billiard-ball interactions, assuming a frictionless table and balls interacting without friction.

This physical manifestation of the reversible concept grew from Toffoli’s idea that computational concepts could be a better way to encapsulate physics than the differential equations conventionally used to describe motion and change. Fredkin took things even further, concluding that the whole Universe could actually be seen as a kind of computer. In his view, it was a ‘cellular automaton’: a collection of computational bits, or cells, that can flip states according to a defined set of rules determined by the states of the cells around them. Over time, these simple rules can give rise to all the complexities of the cosmos — even life.

He wasn’t the first to play with such ideas. Konrad Zuse — a German civil engineer who, before the Second World War, had developed one of the first programmable computers — suggested in his 1969 book Calculating Space that the Universe could be viewed as a classical digital cellular automaton. Fredkin and his associates developed the concept with intense focus, spending years searching for examples of how simple computational rules could generate all the phenomena associated with subatomic particles and forces3.

Paralysis can rob people of their ability to speak. Now researchers hope to give it back

That early experience drove his professional interest in helping people communicate.

Now, Henderson’s an author on one of two papers published Wednesday showing substantial advances toward enabling speech in people injured by stroke, accident or disease.

Although still very early in development, these so-called brain-computer interfaces are five times better than previous generations of the technology at “reading” brainwaves and translating them into synthesized speech. The successes suggest it will someday be possible to restore nearly normal communication ability to people like Henderson’s late father.

DARPA and other federal agencies work on strategies to revive America’s chip industry

Tech executives, researchers and government officials are gathering in Seattle this week to figure out ways to add a new dimension to America’s chip industry — figuratively and literally.

“We’re going to talk about a once-in-a-lifetime opportunity to reinvent domestic microelectronics manufacturing,” Mark Rosker, director of the Defense Advanced Research Projects Agency’s Microsystems Technology Office, said today at the opening session of the ERI 2.0 Summit at the Hyatt Regency Seattle.

More than 1,300 attendees signed up for the DARPA event, which follows up on a series of Electronics Resurgence Initiative Summits that were conducted before the COVID-19 pandemic.

Sci­en­tists develop fermionic quan­tum processor

Fermionic atoms adhere to the Pauli exclusion principle, preventing more than one from simultaneously being in the same quantum state. As a result, they are perfect for modeling systems like molecules, superconductors, and quark-gluon plasmas where fermionic statistics are critical.

Using fermionic atoms, scientists from Austria and the USA have designed a new quantum computer to simulate complex physical systems. The processor uses programmable neutral atom arrays and has hardware-efficient fermionic gates for modeling fermionic models.

The group, under the direction of Peter Zoller, showed how the new quantum processor can simulate fermionic models from quantum chemistry and particle physics with great accuracy.

Shattering Conventional Wisdom — Surprising Discovery Could Transform the Future of Electrochemical Devices

Researchers from the University of Cambridge have unveiled a surprising discovery that holds the potential to reshape the landscape of electrochemical devices. This new insight opens the door for the creation of cutting-edge materials and paves the way for enhancements in sectors like energy storage, neuromorphic computing, and bioelectronics.

Electrochemical devices rely on the movement of charged particles, both ions, and electrons, to function properly. However, understanding how these charged particles move together has presented a significant challenge, hindering progress in creating new materials for these devices.

In the rapidly evolving field of bioelectronics, soft conductive materials known as conjugated polymers are used for developing medical devices that can be used outside of traditional clinical settings. For example, this type of material can be used to make wearable sensors that monitor patients’ health remotely or implantable devices that actively treat disease.

Dr. Joni L. Rutter, Ph.D. — Director, National Center for Advancing Translational Sciences — NIH

Dr. Joni L. Rutter, Ph.D., (https://ncats.nih.gov/director/bio) is the Director of the National Center for Advancing Translational Sciences (NCATS — https://ncats.nih.gov/) at the U.S. National Institutes of Health (NIH) where she oversees the planning and execution of the Center’s complex, multifaceted programs that aim to overcome scientific and operational barriers impeding the development and delivery of new treatments and other health solutions. Under her direction, NCATS supports innovative tools and strategies to make each step in the translational process more effective and efficient, thus speeding research across a range of diseases, with a particular focus on rare diseases.

By advancing the science of translation, NCATS helps turn promising research discoveries into real-world applications that improve people’s health. The NCATS Strategic Plan can be found at — https://ncats.nih.gov/strategicplan.

In her previous role as the NCATS deputy director, Dr. Rutter collaborated with colleagues from government, academia, industry and nonprofit patient organizations to establish robust interactions with NCATS programs.

Prior to joining NCATS, Dr. Rutter served as the director of scientific programs within the All of Us Research Program, where she led the scientific programmatic development and implementation efforts to build a national research cohort of at least 1 million U.S. participants to advance precision medicine. During her time at NIH, she also has led the Division of Neuroscience and Behavior at the National Institute on Drug Abuse (NIDA). In this role, she developed and coordinated research on basic and clinical neuroscience, brain and behavioral development, genetics, epigenetics, computational neuroscience, bioinformatics, and drug discovery. Dr. Rutter also coordinated the NIDA Genetics Consortium and biospecimen repository.

Throughout her career, Dr. Rutter has earned an international reputation for her diverse and unique expertise via her journal publications and speaking engagements, and she has received several scientific achievement awards, including the 2022 Rare Disease Legislative Advocates–RareVoice Award for Federal Advocacy and the 2022 FedHealthIT–Women in Leadership Impact Award.

Dr. Rutter received her Ph.D. from the Department of Pharmacology and Toxicology, Dartmouth Medical School, Hanover, New Hampshire, and completed a fellowship at NCI within the Division of Cancer Epidemiology and Genetics.